Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free TEVA Stock Alerts

Teva Pharmaceutical Industries (TEVA) Short Interest Ratio & Short Volume

Teva Pharmaceutical Industries logo
$40.97 +1.72 (+4.37%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$41.36 +0.40 (+0.97%)
As of 10/9/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Teva Pharmaceutical Industries Short Interest Overview

As of September 30, 2026, Teva Pharmaceutical Industries (TEVA) had a short interest of 29.85 million shares sold short, representing 2.58% of the public float. This marks a -5.18% decrease in short interest since the prior report. The short interest ratio (days to cover) is 5.4, meaning it would take 5.4 days of the average trading volume of 5.24 million shares to cover all short positions.

Current Short Interest
29,848,805 shares
Previous Short Interest
31,478,314 shares
Change Vs. Previous Month
-5.18%
Dollar Volume Sold Short
$1.18 billion
Short Interest Ratio
5.4 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
1,165,300,000 shares
Short Percent of Float
2.58%
Today's Trading Volume
14,820,255 shares
Average Trading Volume
5,236,867 shares
Today's Volume Vs. Average
283%
Short Selling Teva Pharmaceutical Industries?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TEVA Short Interest Over Time

TEVA Days to Cover Over Time

TEVA Percentage of Float Shorted Over Time

Teva Pharmaceutical Industries Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202629,848,805 shares $1.18 billion -5.2%2.6%5.4 $39.64
9/15/202631,478,314 shares $1.23 billion +11,467.5%2.7%27.35 $39.16
8/31/202637,614,253 shares $1.36 billion +5.5%3.2%7.71 $36.03
8/14/202635,670,864 shares $1.31 billion +3.9%3.1%6.63 $36.79
7/31/202634,320,980 shares $1.20 billion +4.8%3.0%5.74 $35.05
7/15/202632,741,011 shares $1.03 billion +2.2%2.9%6.51 $31.58
6/30/202632,029,657 shares $1.09 billion -4.0%2.8%5.1 $33.94
6/15/202633,346,891 shares $1.12 billion -1.5%2.9%5.42 $33.66
5/29/202633,869,008 shares $1.20 billion +27.1%3.0%6 $35.32
5/15/202626,651,458 shares $913.80 million -14.4%2.3%3.99 $34.29
4/30/202631,140,457 shares $1.09 billion +4.7%2.7%4 $35.03
4/15/202629,736,398 shares $940.06 million +10.0%2.6%7.1 $31.61
3/31/202627,042,748 shares $814.45 million -28.1%2.4%3.83 $30.12
3/13/202637,623,025 shares $1.07 billion +15.7%3.3%4.24 $28.54
2/27/202632,527,649 shares $1.10 billion -11.2%2.8%5.04 $33.85
2/13/202636,644,722 shares $1.24 billion -3.5%3.2%3.63 $33.96
1/30/202637,953,087 shares $1.29 billion +15.1%3.3%3.48 $34.08
1/15/202632,969,413 shares $1.07 billion +0.3%2.9%2.9 $32.36
12/31/202532,862,069 shares $1.03 billion -26.9%2.9%4.72 $31.21
12/15/202544,936,239 shares $1.35 billion -1.5%3.9%4.12 $30.10
11/28/202545,620,941 shares $1.23 billion -1.8%4.0%4.31 $26.94
11/14/202546,443,487 shares $1.18 billion -7.8%4.1%2.52 $25.40
10/31/202550,392,932 shares $1.03 billion +6.6%4.4%5.82 $20.50
10/15/202547,280,000 shares $936.00 million -5.2%4.1%4.4 $19.80
9/30/202549,880,000 shares $1.01 billion -9.6%N/A4.5 $20.15
9/15/202555,190,000 shares $1.04 billion +9.3%N/A5 $18.90
8/31/202550,510,000 shares $929.69 million +9.2%4.4%4.5 $18.41
8/15/202546,260,000 shares $826.20 million -7.3%N/A4 $17.86
7/31/202549,890,000 shares $771.10 million -6.6%4.4%4.3 $15.46
7/15/202553,420,000 shares $857.07 million +34.0%N/A4.6 $16.04
6/30/202539,870,000 shares $668.22 million -0.3%3.5%3.3 $16.76
6/15/202540,000,000 shares $679.88 million +12.1%3.5%3.3 $17.00
5/31/202535,670,000 shares $598.19 million -7.8%3.2%2.9 $16.77
5/15/202538,700,000 shares $651.32 million +36.1%3.4%3.1 $16.83
4/30/202528,430,000 shares $440.95 million -6.3%N/A2.3 $15.51
4/15/202530,340,000 shares $412.17 million -6.3%2.7%2.4 $13.59
3/31/202532,390,000 shares $498.32 million -6.9%2.9%2.5 $15.39
3/15/202534,800,000 shares $569.85 million +25.1%3.1%2.8 $16.38
2/28/202527,810,000 shares $457.47 million +4.3%2.5%2.2 $16.45
2/15/202526,660,000 shares $432.83 million +19.2%2.4%2.2 $16.24
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
1/31/202522,360,000 shares $398.12 million +41.5%N/A2 $17.81
1/15/202515,800,000 shares $346.02 million -41.8%N/A1.7 $21.90
12/31/202427,130,000 shares $597.95 million +16.8%N/A3.2 $22.04
12/15/202423,220,000 shares $383.13 million +3.6%N/A2.9 $16.50
11/30/202422,410,000 shares $376.04 million +5.8%N/A3.3 $16.78
11/15/202421,190,000 shares $348.26 million +17.1%N/A3.1 $16.44
10/31/202418,090,000 shares $333.76 million -9.1%N/A2.7 $18.45
10/15/202419,910,000 shares $361.57 million -18.7%N/A2.7 $18.16
9/30/202424,490,000 shares $441.31 million -19.3%N/A3 $18.02
9/15/202430,340,000 shares $558.56 million +26.7%N/A3.5 $18.41
8/31/202423,950,000 shares $451.94 million -0.2%N/A2.7 $18.87
8/15/202423,990,000 shares $439.62 million +23.0%N/A2.7 $18.33
7/31/202419,500,000 shares $339.69 million +10.3%N/A1.9 $17.42
7/15/202417,680,000 shares $301.97 million -20.8%N/A1.8 $17.08
6/30/202422,310,000 shares $362.54 million -9.2%N/A2.2 $16.25
6/15/202424,560,000 shares $421.45 million +35.8%N/A2.5 $17.16
5/31/202418,080,000 shares $306.09 million +39.1%N/A1.9 $16.93
5/15/202413,000,000 shares $218.14 million +6.4%N/A1.3 $16.78
4/30/202412,220,000 shares $171.45 million +4.8%N/A1.3 $14.03
4/15/202411,660,000 shares $154.26 million +0.9%N/A1.1 $13.23
3/31/202411,560,000 shares $163.11 million +10.5%N/A1.1 $14.11
3/15/202410,460,000 shares $140.53 million -28.9%N/A1 $13.44
2/29/202414,720,000 shares $193.27 million -4.4%N/A1.4 $13.13
2/15/202415,390,000 shares $202.99 million -16.0%N/A1.5 $13.19
1/31/202418,320,000 shares $221.67 million +9.3%N/A1.8 $12.10
1/15/202416,760,000 shares $189.72 million +2.5%N/A1.9 $11.32
12/31/202316,350,000 shares $170.69 million +15.8%N/A1.9 $10.44
12/15/202314,120,000 shares $140.92 million +6.1%N/A1.7 $9.98
11/30/202313,310,000 shares $130.77 million -6.1%N/A1.5 $9.83
11/15/202314,180,000 shares $127.19 million -18.9%N/A1.7 $8.97
10/31/202317,490,000 shares $150.06 million +19.2%N/A2.1 $8.58
10/15/202314,670,000 shares $127.04 million +8.1%N/A1.6 $8.66
9/30/202313,570,000 shares $138.41 million -19.5%N/A1.4 $10.20
9/15/202316,850,000 shares $178.10 million -0.3%N/A1.8 $10.57
8/31/202316,900,000 shares $164.94 million -18.4%N/A1.7 $9.76
8/15/202320,710,000 shares $197.47 million -8.8%N/A1.7 $9.54
7/31/202322,710,000 shares $190.65 million +18.7%N/A1.6 $8.40
7/15/202319,130,000 shares $157.06 million +18.7%N/A1.5 $8.21
6/30/202316,120,000 shares $121.30 million -24.4%N/A1.2 $7.53
6/15/202321,330,000 shares $161.68 million +0.1%N/A1.6 $7.58
5/31/202321,300,000 shares $153.15 million +52.5%N/A1.6 $7.19
5/15/202313,970,000 shares $112.74 million +9.7%N/A1.2 $8.07
4/30/202312,730,000 shares $111.13 million -16.6%N/A1.4 $8.73
4/15/202315,260,000 shares $126.51 million -7.4%N/A1.7 $8.29
3/31/202316,480,000 shares $145.85 million -15.9%N/A1.8 $8.85
3/15/202319,590,000 shares $169.85 million -23.4%N/A2.2 $8.67
2/28/202325,570,000 shares $253.40 million -7.6%N/A2.9 $9.91
2/15/202327,680,000 shares $285.38 million -2.4%N/A3.1 $10.31
1/31/202328,350,000 shares $298.81 million +13.3%N/A2.9 $10.54
1/15/202325,020,000 shares $281.22 million -20.5%N/A2.6 $11.24
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
12/30/202231,470,000 shares $287.01 million +31.2%N/A3.3 $9.12
12/15/202223,980,000 shares $214.86 million -22.7%N/A2.6 $8.96
11/30/202231,030,000 shares $272.13 million +0.7%N/A3.4 $8.77
11/15/202230,810,000 shares $282.84 million +2.1%N/A3.3 $9.18
10/31/202230,190,000 shares $269.29 million +3.8%N/A2.9 $8.92
10/15/202229,080,000 shares $231.19 million -0.2%N/A2.3 $7.95
9/30/202229,150,000 shares $235.24 million +12.4%N/A2.2 $8.07
9/15/202225,940,000 shares $230.61 million +28.0%N/A1.9 $8.89
8/31/202220,270,000 shares $183.24 million -9.8%N/A1.4 $9.04
8/15/202222,460,000 shares $251.55 million +11.8%N/A1.6 $11.20
7/31/202220,090,000 shares $188.44 million +13.1%N/A1.5 $9.38
7/15/202217,760,000 shares $124.50 million +4.1%N/A1.7 $7.01
6/30/202217,060,000 shares $128.29 million -12.0%N/A1.7 $7.52
6/15/202219,380,000 shares $157.56 million +1.8%1.8%1.9 $8.13
5/31/202219,040,000 shares $173.26 million -7.0%N/A2.2 $9.10
5/15/202220,470,000 shares $158.85 million +21.2%N/A2.3 $7.76
4/30/202216,890,000 shares $147.11 million -7.5%N/A1.9 $8.71
4/15/202218,260,000 shares $186.07 million -12.7%N/A2.1 $10.19
3/31/202220,910,000 shares $196.34 million -3.7%N/A2.3 $9.39
3/15/202221,720,000 shares $162.90 million +5.4%N/A2.4 $7.50
2/28/202220,610,000 shares $167.56 million +12.3%N/A2.2 $8.13
2/15/202218,360,000 shares $155.33 million -16.6%N/A1.9 $8.46
1/31/202222,020,000 shares $185.63 million +4.3%N/A2.3 $8.43
1/15/202221,110,000 shares $193.58 million +14.1%N/A2 $9.17
12/31/202118,500,000 shares $148.19 million -7.7%N/A1.9 $8.01
12/15/202120,040,000 shares $163.73 million +3.7%N/A2.1 $8.17
11/30/202119,330,000 shares $159.47 million -1.3%N/A2 $8.25
11/15/202119,590,000 shares $184.93 million +1.8%N/A2.3 $9.44
10/29/202119,240,000 shares $168.16 million +9.4%N/A2.3 $8.74
10/15/202117,590,000 shares $170.27 million -10.3%N/A2.2 $9.68

TEVA Short Interest - Frequently Asked Questions

Short interest is the volume of Teva Pharmaceutical Industries shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 29,848,805 shares of TEVA short. 2.58% of Teva Pharmaceutical Industries' shares are currently sold short. Learn More on Teva Pharmaceutical Industries' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TEVA shares currently have a short interest ratio of 5.4. Learn More on Teva Pharmaceutical Industries's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.58% of Teva Pharmaceutical Industries' floating shares are currently sold short.

Teva Pharmaceutical Industries saw a drop in short interest during the month of September. As of September 30th, there was short interest totaling 29,848,805 shares, a drop of 5.2% from the previous total of 31,478,314 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.58% of Teva Pharmaceutical Industries' shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to Teva Pharmaceutical Industries: AbbVie Inc. (0.92%), Novo Nordisk A/S (0.71%), Pfizer Inc. (2.65%), Bristol Myers Squibb Company (2.25%), Sanofi (0.44%), GSK PLC Sponsored ADR (0.81%), Takeda Pharmaceutical Co. (0.09%), BeOne Medicines Ltd. - Sponsored ADR (1.88%), Royalty Pharma PLC (2.76%), Zoetis Inc. (4.47%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling TEVA is an investing strategy that aims to generate trading profit from Teva Pharmaceutical Industries as its price is falling. TEVA shares are trading up $1.72 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Teva Pharmaceutical Industries occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TEVA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TEVA, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TEVA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:TEVA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel